Learn more about COSENTYX® (secukinumab), a treatment option for PsO, HS, PsA, AS, nr-axSpA, pediatric PsO, and pediatric JIA. See full prescribing and safety information. Skip to main content

COSENTYX® (secukinumab) is an injection that can be taken with a variety of devices—and there are plenty of resources to help. Learn more about each of the devices below and get tips for how to develop a personal monthly injection routine with COSENTYX.

2023年11月1日 · Cosentyx (secukinumab) is used to treat types of plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, enthesitis-related arthritis, hidradenitis suppurativa (HS), and non-radiographic axial spondyloarthritis, which are autoimmune conditions.

2023年11月2日 · Cosentyx (secukinumab) is an immunosuppressant injection that reduces the effects of a chemical substance in the body that can cause inflammation. The FDA has approved use of Cosentyx to treat moderate to severe plaque psoriasis (raised, silvery flaking of the skin) in patients over 6 years old.

COSENTYX® [koe-sen-tix] (secukinumab) injection, for subcutaneous use 300 mg/2 mL single-dose prefilled syringe Be sure that you read, understand, and follow this Instructions for Use before injecting COSENTYX. Your healthcare provider should show you how to prepare and inject COSENTYX properly using the prefilled syringe before you use it for

Access instructions for injecting the 150 mg COSENTYX® (secukinumab) Sensoready® Pen. Discover videos and administration tips. See full prescribing & safety information.

COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: •moderate to severe plaque psoriasis (PsO)in patients 6 years and older who are candidates for systemic therapy or phototherapy. (1.1) •active psoriatic arthritis (PsA)in patients 2 years of age and older. (1.2) •adults with active ankylosing spondylitis (AS).

Adult patients may be injected by a caregiver or self-administer COSENTYX after proper training in subcutaneous injection technique using the Sensoready ® pen or prefilled syringe. Pediatric patients should not self-administer COSENTYX using the Sensoready pen or prefilled syringe.

•COSENTYX is given as an injection under your skin (subcutaneous injection), in your upper legs (thighs) or stomach-area (abdomen) by you or a caregiver. A caregiver or healthcare provider may also give you an injection of COSENTYX in your upper outer arm.

COSENTYX is indicated for the treatment of moderate to severe plaque psoriasis (PsO) in patients 6 years and older who are candidates for systemic therapy or phototherapy. COSENTYX is indicated for the treatment of active psoriatic arthritis (PsA) in patients 2 years of age and older.